SCHEMBL7577205

SCHEMBL7577205

Cc1ccccc1-c1cc(NCc2cccnc2)ccc1C#N

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 8/20 0.57
CYP1A2 P05177 7/20 0.57
CYP2C19 P33261 7/20 0.57
CYP2C9 P11712 2/20 0.57
ALDH1A1 P00352 8/20 0.54
HSD17B10 Q99714 5/20 0.54
CYP2D6 P10635 4/20 0.54
MAPK1 P28482 3/20 0.54
ALOX15 P16050 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
THRB P10828 1/20 0.54
HPGD P15428 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
CLK4 Q9HAZ1 4/20 0.52
MAPT P10636 3/20 0.49
PABPC1 P11940 1/20 0.49
LTA4H P09960 1/20 0.49
PGK1 P00558 1/20 0.48
TSHR P16473 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7570115 0.86 RAB9A (0.52) CYP3A4CYP1A2CYP2C19CYP2C9ALDH1A1
SCHEMBL7572481 0.85 HTT (0.54) CYP3A4CYP1A2CYP2C19CYP2C9ALDH1A1
SCHEMBL7572173 0.78 FNTA (0.50)
SCHEMBL6982380 0.76 NR1D1 (0.44)
SCHEMBL7423977 0.76 MAPT (0.56) CYP3A4CYP1A2CYP2C19CYP2C9ALDH1A1
Hydrochloric Acid SCHEMBL7567497 0.76 NR1D1 (0.44)
SCHEMBL7085038 0.76 FNTA (0.47)
SCHEMBL22530409 0.75 ALDH1A1 (0.55) CYP3A4CYP1A2CYP2C19CYP2C9ALDH1A1
SCHEMBL10558180 0.72 CYP3A4 (0.68) CYP3A4CYP1A2CYP2C19CYP2C9ALDH1A1
SCHEMBL5714168 0.71 ALDH1A1 (0.64) CYP3A4CYP1A2CYP2C19ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors ABBOTT LABORATORIES 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors FNTA, FNTB, SLC10A1 CYP3A4 269/4885CYP1A2 276/4885CYP2C19 486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.